...
首页> 外文期刊>AJR: American Journal of Roentgenology : Including Diagnostic Radiology, Radiation Oncology, Nuclear Medicine, Ultrasonography and Related Basic Sciences >Tumor staging of advanced esophageal cancer: combination of double-contrast esophagography and contrast-enhanced CT.
【24h】

Tumor staging of advanced esophageal cancer: combination of double-contrast esophagography and contrast-enhanced CT.

机译:晚期食管癌的肿瘤分期:双重对比食管造影和增强CT。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: The objective of this study was to compare the diagnostic accuracy of tumor staging in patients with advanced esophageal cancer based on contrast-enhanced CT findings alone with that based on a combination of CT and double-contrast esophagography and to evaluate the relevance of tumor stage to survival rate. MATERIALS AND METHODS: In 94 patients who underwent surgery as the primary treatment for esophageal cancer and had a diagnosis of postoperative T stage 3 (pT3) or pT4 disease based on pathologic examination, T stage was evaluated using CT alone and using a combination of CT and double-contrast esophagography. The diagnostic criterion for T4 disease using CT alone was tumor strongly displacing or deforming adjacent organs. The diagnostic criterion for T4 disease using the combined method was tumor displacing or deforming adjacent organs in the direction that corresponded to the direction of the location of the tumor or the deepest ulcer as diagnosed by barium esophagography. Concordance of T staging based on imaging with postoperative T staging based on pathology results, the gold standard, and survival rate were assessed for CT alone and for the combined method. RESULTS: The concordance rate with postoperative T staging pathology results was 78% for CT alone and 84% for CT and double-contrast esophagography combined, with a significant difference between the two diagnostic methods. For patients with a diagnosis of T3 and those with a diagnosis of T4 using CT alone, the 3-year survival rate was 42% and 26%, respectively, with no significant difference between the two. For patients with a diagnosis of T3 and those with a diagnosis of T4 using the combined method, the 3-year survival rate was 42% and 21%, respectively, with a significant difference between the two. CONCLUSION: The diagnostic performance of contrast-enhanced CT and double-contrast esophagography combined in staging advanced esophageal tumors is better than that of CT alone and thus has potential for estimating prognosis.
机译:目的:本研究的目的是比较仅根据对比增强的CT表现与结合CT和双对比食管造影的结果对晚期食管癌患者的肿瘤分期的诊断准确性,并评估肿瘤的相关性生存率的阶段。材料与方法:94例接受手术作为食道癌的主要治疗方法并经病理检查诊断为术后T期3期(pT3)或pT4疾病的患者,仅使用CT或结合CT评估了T期和双重对比的食管造影仅使用CT的T4疾病的诊断标准是肿瘤强烈移位或使邻近器官变形。使用联合方法对T4疾病的诊断标准是肿瘤移位或使邻近器官变形,该方向对应于钡餐镜检查所诊断的肿瘤或最深溃疡的位置。单独评估CT和联合方法评估基于影像学的T分期与基于病理结果,金标准和生存率的术后T分期的一致性。结果:单独的CT与术后T分期病理结果的符合率分别为78%,CT和双对比食管造影的84%,两种诊断方法之间存在显着差异。对于诊断为T3的患者和仅使用CT诊断为T4的患者,其3年生存率分别为42%和26%,两者之间无显着差异。对于使用合并方法诊断为T3的患者和诊断为T4的患者,其3年生存率分别为42%和21%,两者之间存在显着差异。结论:增强CT和双对比食管造影在分期晚期食管肿瘤中的诊断性能优于单纯CT,因此具有评估预后的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号